Short answer
HCA Healthcare (HCA) filed an 8-K current report with the SEC on July 14, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Preliminary second-quarter results for period ended June 30, 2026.
HCA Healthcare 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Preliminary second-quarter results for period ended June 30, 2026
- HCA issued results announcement on July 14, 2026
- Key financial figures and management commentary available in Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- Preliminary Q2 2026 operating results for quarter ended June 30, 2026
- Press release issued July 14, 2026 under Regulation FD
- Exhibit 99.1 contains the detailed financial results for investor review
Item EX-99.1 · Exhibit EX-99.1
- Preliminary Q2 revenue $20.230B versus $18.605B; net income $1.699B versus $1.653B; EPS $7.62 versus $6.83
- Same-facility admissions rose 2.5%, equivalent admissions 2.7%, and ER visits 3.6%; inpatient and outpatient surgeries declined 2.3% and 3.4%
- Uninsured volume and exchange coverage losses reduced pretax income by approximately $400M; full-year exchange impact now estimated at $1.000B-$1.200B
- Medicaid supplemental payments provided approximately $400M incremental Q2 benefit; full-year estimate raised to $300M-$500M
- 2026 guidance lowered: revenue $77.000B-$79.500B, net income $6.300B-$6.700B, EBITDA $15.400B-$16.100B, EPS $28.70-$30.50
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HCA Healthcare 8-K filings
Get the next HCA 8-K as it lands
Follow HCA for push alerts, or ask the research agent what this filing means.